Detalles de la búsqueda
1.
[The 505th case: refractory ascites and monoclonal immunoglobulin].
Zhonghua Nei Ke Za Zhi
; 63(5): 517-520, 2024 May 01.
Artículo
en Zh
| MEDLINE | ID: mdl-38715493
2.
[The 503rd case: monoclonal IgM immunoglobulinemia, severe anemia with recurrent fever].
Zhonghua Nei Ke Za Zhi
; 62(11): 1369-1372, 2023 Nov 01.
Artículo
en Zh
| MEDLINE | ID: mdl-37935507
3.
[Efficacy and prognostic analysis of orthopedic surgery in patients with newly diagnosed multiple myeloma].
Zhonghua Nei Ke Za Zhi
; 62(6): 673-680, 2023 Jun 01.
Artículo
en Zh
| MEDLINE | ID: mdl-37263950
4.
[Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Zhonghua Nei Ke Za Zhi
; 62(4): 416-421, 2023 Apr 01.
Artículo
en Zh
| MEDLINE | ID: mdl-37032137
5.
[The 502nd case: thrombocytopenia, splenomegaly, disseminated intravascular coagulation, and spontaneous rupture of the spleen].
Zhonghua Nei Ke Za Zhi
; 62(10): 1249-1252, 2023 Oct 01.
Artículo
en Zh
| MEDLINE | ID: mdl-37766449
6.
[Efficacy of different regimens and prognostic factors in patients with first relapsed multiple myeloma treated after front-line bortezomib, cyclophosphamide, and dexamethasone].
Zhonghua Nei Ke Za Zhi
; 62(12): 1436-1443, 2023 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-38044070
7.
[The 492nd case: recurrent thrombosis, thrombocytopenia].
Zhonghua Nei Ke Za Zhi
; 61(2): 239-242, 2022 Feb 01.
Artículo
en Zh
| MEDLINE | ID: mdl-35090264
8.
[The 491st case: thrombocytosis, gastrointestinal hemorrhage, intestinal perforation].
Zhonghua Nei Ke Za Zhi
; 60(12): 1193-1196, 2021 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-34856696
9.
[A case of multiple myeloma accompanied with breast cancer and lung cancer].
Zhonghua Nei Ke Za Zhi
; 61(10): 1158-1160, 2022 Oct 01.
Artículo
en Zh
| MEDLINE | ID: mdl-36207971
10.
[Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report].
Zhonghua Nei Ke Za Zhi
; 61(12): 1369-1372, 2022 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-36456521
11.
[Clinical analysis of Sweet syndrome with myelodysplasia syndrome].
Zhonghua Yi Xue Za Zhi
; 96(22): 1755-7, 2016 Jun 14.
Artículo
en Zh
| MEDLINE | ID: mdl-27356643
12.
[The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment].
Zhonghua Xue Ye Xue Za Zhi
; 44(2): 141-147, 2023 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36948869
13.
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms].
Zhonghua Xue Ye Xue Za Zhi
; 44(3): 193-201, 2023 Mar 14.
Artículo
en Zh
| MEDLINE | ID: mdl-37356980
14.
[Clinical characteristics and prediction model of early death in severe/very severe aplastic anemia with immunosuppressive therapy].
Zhonghua Xue Ye Xue Za Zhi
; 43(11): 916-920, 2022 Nov 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709182
15.
[Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10].
Zhonghua Xue Ye Xue Za Zhi
; 42(4): 295-301, 2021 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-33979973
16.
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].
Zhonghua Xue Ye Xue Za Zhi
; 42(12): 985-992, 2021 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-35045668
17.
[Quality of life of 22 patients with type 1 Gaucher disease after enzyme replacement therapy].
Zhonghua Xue Ye Xue Za Zhi
; 41(4): 287-291, 2020 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32447931
18.
[The value of serum heavy/light chain immunoassay to assess therapeutic response in patients with multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 39(4): 281-285, 2018 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-29779321
19.
[Posaconazole as primary prevention of fungal infection in intensive immunosuppressive therapy for severe aplastic anemia].
Zhonghua Xue Ye Xue Za Zhi
; 39(2): 128-131, 2018 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-29562447
20.
[Analysis of the efficacy and survival of ixazomib-containing regimens in patients with refractory and relapsed multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 43(8): 680-684, 2022 08 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709154